(Q33378748)

26 July 2017

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

12

G Fountzilas

1 reference

26 July 2017

A Koumarianou

6

0 references

author name string

D Pectasides

1

1 reference

26 July 2017

N Xiros

2

1 reference

26 July 2017

G Papaxoinis

3

1 reference

26 July 2017

E Pectasides

4

1 reference

26 July 2017

C Sykiotis

5

1 reference

26 July 2017

A Psyrri

7

1 reference

26 July 2017

A Gaglia

8

1 reference

26 July 2017

D Kassanos

9

1 reference

26 July 2017

P Gouveris

10

1 reference

26 July 2017

J Panayiotidis

11

1 reference

26 July 2017

T Economopoulos

13

1 reference

26 July 2017

language of work or name

English

0 references

publication date

4 March 2008

1 reference

26 July 2017

1 reference

26 July 2017

109

1 reference

26 July 2017

250-254

1 reference

26 July 2017

2

1 reference

26 July 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.028

10.1016/J.YGYNO.2008.01.028

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference